Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
1.050
0.00 (0.00%)
At close: Sep 25, 2026, 4:00 PM EDT
1.060
+0.010 (0.95%)
After-hours: Sep 25, 2026, 4:10 PM EDT
Citius Oncology Market Cap
Citius Oncology has a market cap or net worth of $111.05 million as of September 25, 2026. Its market cap has decreased by -26.54% in one year.
Market Cap
111.05M
Enterprise Value
104.69M
1-Year Change
-26.54%
Ranking
Category
Stock Price
$1.05
ChartMarket Cap Chart
Since December 8, 2022, Citius Oncology's market cap has increased from $90.21M to $111.05M, an increase of 23.09%. That is a compound annual growth rate of 5.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 111.05M | 30.95% |
| Dec 31, 2025 | 84.80M | 3.05% |
| Dec 31, 2024 | 82.29M | -15.88% |
| Dec 29, 2023 | 97.81M | 7.68% |
| Dec 30, 2022 | 90.84M | 0.69% |
| Dec 8, 2022 | 90.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cardiol Therapeutics | 200.79M |
| Organogenesis Holdings | 181.43M |
| Journey Medical | 173.30M |
| ADC Therapeutics | 162.14M |
| Lifecore Biomedical | 158.98M |
| Organigram Global | 155.59M |
| Cumberland Pharmaceuticals | 114.02M |
| BGM Group | 96.15M |